Associate Professor, Internal Medicine, University Kansas School of Medicine
Nephrology
Dr. James B. Wetmore, MD
|
|
Give Review
James Wetmore is an expert in the field of Nephrology. He attended University of Alabama Medical Center. University of Alabama Medical Center has a rank of 37 in research and a 17 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". James Wetmore is a published doctor. He has 44 papers published. The most current publication "Infections Requiring Hospitalization in Patients on Hemodialysis." James Wetmore accepts Medicare payments and is registered with Medicare.gov.
Publications
- Meeting the World's Need for Maintenance Dialysis.
- Infections Requiring Hospitalization in Patients on Hemodialysis.
- Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates With Coronary Atherosclerosis Burden.
- Association between higher rates of cardioprotective drug use and survival in patients on dialysis.
- Clinical Outcomes after Parathyroidectomy in a Nationwide Cohort of Patients on Hemodialysis.
- Polycystic Kidney Disease and Cancer after Renal Transplantation.
- Race, Ethnicity, and State-by-State Geographic Variation in Hemorrhagic Stroke in Dialysis Patients.
- Implications of predonation GFR to recipient and donor outcomes.
- Painless Myocardial Ischemia Is Associated with Mortality in Patients with Chronic Kidney Disease.
- Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating Chronic dialysis.
- Atrial fibrillation and risk of stroke in dialysis patients.
- The medicinal use of water in renal Disease.
- Impact of race on cumulative exposure to antiHypertensive medications in dialysis.
- Ethnic differences in 25-hydroxyvitamin D levels and response to treatment in CKD.
- Association of Race With Cumulative Exposure to Statins in Dialysis.
- Geographic Variation in HMG-CoA Reductase Inhibitor Use in Dialysis Patients.
- A CD3+ count-based thymoglobulin induction regimen permits delayed introduction of calcineurin inhibitors in Kidney transplantation.
- The prevalence of and factors associated with Chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients.
- Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with Acute myocardial infarction: a cross-sectional analysis.
- The link between estrogen and fibroblast growth factor 23.
- Transient Impact of Automated Glomerular Filtration Rate Reporting on Drug Dosing for Hospitalized Older Adults With Concealed Renal Insufficiency.
- Geographic Variation in Cardioprotective AntiHypertensive Medication Usage in Dialysis Patients.
- Does it Matter How Parathyroid Hormone Levels are Suppressed in Secondary Hyperparathyroidism?
- Implications of donor disseminated intravascular coagulation on Kidney allograft recipients.
- Association of decreased glomerular filtration rate with racial differences in survival after Acute myocardial infarction.
- Elevated FGF23 levels are associated with impaired Calcium-mediated suppression of PTH in ESRD.
- Economic analysis of cinacalcet in combination With low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
- Role of lean body mass in estimating glomerular filtration rate in Alzheimer Disease.
- Review: insufficient evidence exists on the benefit of vitamin D in patients with chronic Kidney disease not requiring dialysis.
- Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD.
- The ABCs of cardioprotection in dialysis patients: a systematic review.
- Interleukin-1 gene cluster polymorphisms predict risk of ESRD.
- Deep brain stimulation for Parkinson''s Disease: association between stimulation parameters and cognitive performance.
- Primary amyloidosis of the Kidney.
- Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal Disease: time for a paradigm shift?
- Associations of interleukin-6, C-reactive protein and serum amyloid A With mortality in haemodialysis patients.
- Oral paricalcitol: a viewpoint by james B. Wetmore and L. Darryl quarles.
- An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal Disease.
- Effects of short-term alendronate on bone Mineral density in haemodialysis patients.
- Considering health insurance: how do dialysis initiates With Medicaid coverage differ from persons Without Medicaid coverage?
- Treatment of secondary hyperparathyroidism in Kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs.
- Discrepancies between creatinine- and cystatin C-based equations: implications for identification of chronic Kidney disease in the general population.
- Improvement of hemodialysis catheter function With tenecteplase: a phase III, open-label study: TROPICS 4.
Schools
University of Texas Southwestern Medical Center At Dallas
University Of Alabama Hospital
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF -
University of Alabama Medical Center -
University of Texas Southwestern Medical School
Hospital
-
The University of Kansas Hospital
Drug Facts
| NPI NUMBER | 1467555383 | |
| NPPES Provider LastName | WETMORE | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 554151623 | |
| NPPES Provider State | MN | |
| Specialty Description | Nephrology | |
| Total Claim Count | 317.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467555383 |
| Last Name Of The Provider | WETMORE |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Elizabeth W. Dehmer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arnold M. Chonko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronnie Moussa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Alderson, MD |
|
|
Dr. Sri G. Yarlagadda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aditi Gupta, MD |
|
|
Dr. Ellen T. McCarthy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Munis Azim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian R. Ringhofer, MD
This Doctor is OpenDoctor Recommended.
|